Over half of Americans (51 percent) report using a wearable fitness tracker at least once a day, according to a report conducted by Researchscape International.

Researchers with the U.S. Military HIV Research Program have developed an experimental heroin vaccine capable of preventing the drug from passing the blood-brain barrier in mice. Findings were published in the Journal of Medicinal Chemistry.

Adding music therapy to conventional depression treatments could improve patient outcomes, according to a study published in Cochrane Library.

Engineers from Cornell University have developed a microchip “tag” capable of collecting vital signs form a distance using radio frequency signals. The method is outlined in a study published in Nature Electronics.

Researchers from Worcester Polytechnic Institute (WPI) from Worcester, Massachusetts, and the University of Connecticut have developed a smartphone app that uses machine learning to predict eating patterns to provide potential interventions for users hoping to lose weight. Findings were presented at the annual symposium for the American Medical Informatics Association.

Belgian researchers have identified a protein formulation that mimics the structure and rigidity of the natural lining in a women’s ovaries, a breakthrough for women with infertility or cancer patients who had radiation or chemotherapy treatments. Findings are published in the Journal of Assisted Reproduction and Genetics.

NewYork-Presbyterian and Walgreens are collaborating to bring convenient access to NewYork-Presbyterian’s world-class care through new telemedicine services, now available through Walgreens digital properties and at self-service kiosks at select Duane Reade drugstores in New York.  NewYork-Presbyterian, New York’s No. 1 hospital, is offering the telemedicine services as part of its NYP OnDemand suite of digital health services.

The healthcare industry can seem overloaded with new technological experiments, but companies focusing on implementation are ahead of the game, according to Forbes' David Shaywitz.